Danaher (DHR): Q3 adjusted profit per share up 11.5% to $2.11 and full-year outlook raised to $8.57 to $8.62
Danaher, which makes the instruments, supplies and tests used in laboratories and hospitals, said third-quarter sales rose 8.5% to $6.55bn and…